We provide you with 20 years of free, institutional-grade data for VRNA stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of VRNA. Explore the full financial landscape of VRNA stock.
| Reported Date | CIK | Ticker | Type | |
|---|---|---|---|---|
| 2025-08-06 | 1657312 | VRNA | 10-Q | Url |
| 2025-04-29 | 1657312 | VRNA | 10-Q | Url |
| 2025-02-27 | 1657312 | VRNA | 10-K | Url |
| 2024-11-04 | 1657312 | VRNA | 10-Q | Url |
| 2024-08-08 | 1657312 | VRNA | 10-Q | Url |
| 2024-05-10 | 1657312 | VRNA | 10-Q | Url |
| 2024-02-29 | 1657312 | VRNA | 10-K | Url |
| 2023-11-02 | 1657312 | VRNA | 10-Q | Url |
| 2023-08-03 | 1657312 | VRNA | 10-Q | Url |
| 2023-05-09 | 1657312 | VRNA | 10-Q | Url |
| 2023-03-07 | 1657312 | VRNA | 10-K | Url |
| 2022-11-09 | 1657312 | VRNA | 10-Q | Url |
| 2022-08-09 | 1657312 | VRNA | 10-Q | Url |
| 2022-05-03 | 1657312 | VRNA | 10-Q | Url |
| 2022-03-03 | 1657312 | VRNA | 10-K | Url |
| 2021-11-09 | 1657312 | VRNA | 10-Q | Url |
| 2021-08-05 | 1657312 | VRNA | 10-Q | Url |
| 2021-04-29 | 1657312 | VRNA | 10-Q | Url |
| 2021-02-25 | 1657312 | VRNA | 10-K | Url |
| 2020-12-30 | 1657312 | VRNA | 6-K | Url |
| 2020-11-24 | 1657312 | VRNA | 6-K | Url |
| 2020-11-12 | 1657312 | VRNA | 6-K | Url |
| 2020-10-29 | 1657312 | VRNA | 6-K | Url |
| 2020-09-25 | 1657312 | VRNA | 6-K | Url |
| 2020-09-22 | 1657312 | VRNA | 6-K | Url |
| 2020-09-14 | 1657312 | VRNA | 6-K | Url |
| 2020-08-27 | 1657312 | VRNA | 6-K | Url |
| 2020-08-19 | 1657312 | VRNA | 6-K | Url |
| 2020-08-14 | 1657312 | VRNA | 6-K | Url |
| 2020-08-10 | 1657312 | VRNA | 6-K | Url |
| 2020-07-22 | 1657312 | VRNA | 6-K | Url |
| 2020-07-20 | 1657312 | VRNA | 6-K | Url |
| 2020-05-14 | 1657312 | VRNA | 6-K | Url |
| 2020-04-30 | 1657312 | VRNA | 6-K | Url |
| 2020-04-16 | 1657312 | VRNA | 6-K | Url |
| 2020-04-14 | 1657312 | VRNA | 6-K | Url |
| 2020-04-06 | 1657312 | VRNA | 6-K | Url |
| 2020-03-30 | 1657312 | VRNA | 6-K | Url |
| 2020-03-30 | 1657312 | VRNA | 6-K | Url |
| 2020-03-10 | 1657312 | VRNA | 6-K | Url |
| 2020-02-27 | 1657312 | VRNA | 20-F | Url |
| 2020-02-04 | 1657312 | VRNA | 6-K | Url |
| 2020-01-17 | 1657312 | VRNA | 6-K | Url |
| 2019-11-29 | 1657312 | VRNA | 6-K | Url |
| 2019-11-22 | 1657312 | VRNA | 6-K | Url |
| 2019-11-22 | 1657312 | VRNA | 6-K | Url |
| 2019-11-05 | 1657312 | VRNA | 6-K | Url |
| 2019-09-19 | 1657312 | VRNA | 6-K | Url |
| 2019-08-14 | 1657312 | VRNA | 6-K | Url |
| 2019-08-08 | 1657312 | VRNA | 6-K | Url |
| 2019-08-07 | 1657312 | VRNA | 6-K | Url |
| 2019-06-05 | 1657312 | VRNA | 6-K | Url |
| 2019-05-14 | 1657312 | VRNA | 6-K | Url |
| 2019-05-07 | 1657312 | VRNA | 6-K | Url |
| 2019-05-03 | 1657312 | VRNA | 6-K | Url |
| 2019-04-12 | 1657312 | VRNA | 6-K | Url |
| 2019-03-26 | 1657312 | VRNA | 6-K | Url |
| 2019-03-26 | 1657312 | VRNA | 6-K | Url |
| 2019-03-19 | 1657312 | VRNA | 20-F | Url |
| 2019-03-12 | 1657312 | VRNA | 6-K | Url |
| 2019-02-28 | 1657312 | VRNA | 6-K | Url |
| 2019-01-04 | 1657312 | VRNA | 6-K | Url |
| 2018-11-06 | 1657312 | VRNA | 6-K | Url |
| 2018-09-25 | 1657312 | VRNA | 6-K | Url |
| 2018-08-14 | 1657312 | VRNA | 6-K | Url |
| 2018-08-07 | 1657312 | VRNA | 6-K | Url |
| 2018-06-28 | 1657312 | VRNA | 6-K | Url |
| 2018-06-04 | 1657312 | VRNA | 6-K | Url |
| 2018-05-08 | 1657312 | VRNA | 6-K | Url |
| 2018-05-04 | 1657312 | VRNA | 6-K | Url |
| 2018-05-04 | 1657312 | VRNA | 6-K | Url |
| 2018-04-18 | 1657312 | VRNA | 6-K | Url |
| 2018-03-29 | 1657312 | VRNA | 6-K | Url |
| 2018-03-22 | 1657312 | VRNA | 6-K | Url |
| 2018-02-27 | 1657312 | VRNA | 20-F | Url |
| 2017-11-09 | 1657312 | VRNA | 6-K | Url |
| 2017-09-21 | 1657312 | VRNA | 6-K | Url |
| 2017-09-12 | 1657312 | VRNA | 6-K | Url |
| 2017-08-24 | 1657312 | VRNA | 6-K | Url |
| 2017-08-08 | 1657312 | VRNA | 6-K | Url |
| 2017-05-26 | 1657312 | VRNA | 6-K | Url |
| 2017-05-18 | 1657312 | VRNA | 6-K | Url |
| 2017-05-03 | 1657312 | VRNA | 6-K | Url |
Verona Pharma plc(NASDAQ:VRNA) 
Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. Its product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 ...
Website: http://www.veronapharma.com
Founded: 2005
Full Time Employees: 33
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about VRNA stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.